Skip to main content Back to Top

News and Press Releases

5/28/2014 Press Release

ASHP Awards Harvey A.K. Whitney, Jr., Honorary Membership

The American Society of Health-System Pharmacists (ASHP) has named Harvey A.K. Whitney, Jr., M.S., an honorary member of ASHP for his sustained contributions to health-system pharmacy practice. Whitney, president of Harvey Whitney Books Co., has dedicated his career to advancing the profession of ph

5/28/2014 Press Release

ASHP Awards Michael Cohen Honorary Membership

The American Society of Health-System Pharmacists (ASHP) has named Michael R. Cohen, M.S., Sc.D. (Hon.), D.P.S.(Hon.), FASHP, an honorary member of the Society for his sustained contributions to health-system pharmacy practice. Cohen received the honor today during the Society’s Summer Meetings in L

5/28/2014 Press Release

John Murphy to Receive ASHP’s 2014 Whitney Award

John E. Murphy, Pharm.D., FASHP, FCCP, a pioneer in the field of clinical pharmacokinectics and noted pharmacy educator, is the recipient of the American Society of Health-System Pharmacy’s (ASHP’s) 2014 Harvey A.K. Whitney Lecture Award. Dr. Murphy will receive the award on June 3 during ASHP's Sum

5/28/2014 Press Release

ASHP Recognizes Pharmacists, Pharmacy Department's Care for Patients During Boston Marathon Bombing and Oklahoma Tornado

The pharmacy department of the Massachusetts General Hospital in Boston and Barbara Poe, D.Ph., M.B.A., FASHP, pharmacist-in-charge, Moore Medical Center in Moore, Okla., were honored today with the American Society of Health-System Pharmacists’ (ASHP’s) Chief Executive Officer’s Award for Courageou


Hospitals Don't Miss Codeine After it's Gone

Prescribers seem to have taken in stride decisions to remove codeine from hospital formularies to protect pediatric patients from serious adverse events related to the drug's use. "I think people have adjusted to having alternatives that don't involve codeine," said Lisa T. Thames, pediatric phar


Dalbavancin Approved for Acute Skin Infections

FDA and Durata Therapeutics on May 23 announced the approval of dalbavancin for the treatment of adults with acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. The company plans to launc

5/27/2014 Press Release

ASHP Launches New Quality Improvement Resource Center

ASHP has revised its online Quality Improvement Resource Center to better support pharmacist leadership and engagement in healthcare quality initiatives that improve patient outcomes and reward performance excellence. “Close to 40 percent of clinical quality measures are related either directly or i


New ASHP FAQs Focus on How to Bill for Ambulatory Care Services

A new FAQ document about pharmacist billing for ambulatory patient-care services has just been posted to the ASHP Ambulatory Care Resource Center. This comprehensive document focuses on issues such as the billing differences between physician-based and hospital-based clinics, how pharmacists can use

Showing 1153-1160 of 1995

  • 145
  • OF 250